β¨ Pharmaceutical Schedules
NEW ZEALAND GAZETTE
No. 20
Left Column
nutrition replacement preparations; for external use in medicines containing 2.5% or less but more than 0.1% of elemental fluorine
Folic acid; in medicines containing more than 500 micrograms per recommended daily dose except in parenteral nutrition replacement preparations
Formaldehyde; in medicines containing more than 5%
Gelsemium; except in medicines containing 1 milligram or less per litre or per kilogram
Glyceryl trinitrate; for oral or rectal use; except in medicines containing 100 micrograms or less per litre or per kilogram
Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container
Hydrocyanic acid; for oral use in packs containing 5 milligrams or less and more than 0.5 milligrams; except in medicines containing 1 microgram or less per litre or per kilogram
Indomethacin; for external use in medicines containing 1% or less; except in medicines containing 1 milligram or less per litre or per kilogram
Injectable medicines; except when specified elsewhere in this Schedule; except Factor VIII; except for contrast media, parenteral nutrition replacement preparations or plasma volume expanders
Isopropamide; for dermal use in preparations containing 2% or less
Isosorbide dinitrate; for oral use in medicines containing 10 milligrams or less per dose form
Lithium; for dermal use in medicines containing 1% or less and more than 0.01%
Loperamide; in packs containing not more than 20 tablets or capsules
Paraformaldehyde; in medicines containing more than 5%
Potassium; except when specified elsewhere in the schedule; for internal use in slow release or enteric coated forms; in medicines containing more than 100 milligrams per recommended dose except in medicines for oral rehydration therapy, parenteral nutrition replacement or dialysis
Propamidine; for ophthalmic use
Pseudoephedrine; In cough or decongestant medicines containing not more than 240 milligrams per recommended daily dose either: in slow release preparations; or in liquid preparations containing not more than 60 milligrams per recommended dose; or when compounded with other active ingredients; or in solid dose form with no other active ingredients and containing not more than 60 milligrams per recommended dose and in packs containing not more than 30 dose units
Staphisagria; except in medicines containing 0.2% or less
Zinc chloride; for dermal use in medicines containing more than 5%.
Medicines for General Sale
Please note that the following medicines are no longer classified as prescription medicines, restricted medicines or pharmacy-only medicines. As such, they are now available for general sale.
Acetomenaphthone
Acetylcysteine; for external use
Aconite; for oral use in packs containing 0.02 milligrams or less of total alkaloids; for dermal use in concentrations
Right Column
of 0.02% or less and in packs containing not more than 0.02 milligrams of total alkaloids
Alcohol; except for injection in medicines containing more than 20%
Bentiromide
Bromelains
Broxaldine
Broxyquinoline
Calcium hypochlorite
Calcium salicylate
Camphor, ammoniated
Capsicum oleo-resin
Chromium oxide
Colecalciferol; in medicines for internal use containing 25 micrograms or less per recommended daily dose; in parenteral nutrition replacement preparations
Copper
Cyanocobalamin
Deoxyribonuclease; for external use
Dextranomer
Dextrans
Diamthazole
Dibromopropamidine; except for ophthalmic use
Factor VIII
Fluorescein; except for injection
Fluorides; in parenteral nutrition replacement preparations; for external use in medicines containing 0.1% of elemental fluorine
Folic acid; in medicines containing 500 micrograms or less per recommended daily dose; in parenteral nutrition replacement preparations
Formic acid
Hetastarch
Hexamidine
Hippuric acid
Hyaluronic acid; except for injection
Hydrocyanic acid; for oral use in packs containing 0.5 milligrams or less; in medicines containing 1 microgram or less per litre or per kilogram
Hydrogen peroxide
Hydroiodic acid
Hydroxocobalamin
Ichthammol
Injectable medicines which contain Factor VIII or which are parenteral nutrition replacement preparations, plasma volume expanders or contrast media
Iodic acid
Iron; in medicines containing 24 milligrams or less per recommended daily dose; in parenteral nutrition replacement preparations
Irrigation medicines
Isopropyl alcohol
Jaborandi
Krameria,
Lithium; for dermal use in medicines containing 0.01% or less
Magenta
Menadiol
Methylene blue; except for injection.
Monoacetin
Nitrous ether spirit
Oxerutins
Pentastarch
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 20
Gazette.govt.nz —
NZ Gazette 2002, No 20
β¨ LLM interpretation of page content
π₯
Schedule 3 Pharmacy-only Medicines
(continued from previous page)
π₯ Health & Social WelfarePharmacy-only Medicines, Medicines Act, Controlled Substances, Pharmaceuticals
π₯ Medicines for General Sale
π₯ Health & Social WelfareGeneral Sale Medicines, Pharmaceuticals, Declassification